Person profile
Public information reviewedVincent Aurentz
Board role
Director · Inhibikase Therapeutics, Inc. (NASDAQ: IKT)
Inhibikase Therapeutics, Inc. (NASDAQ: IKT)
Director · Current mandate
Director · Executive
- Public sources
- 3 reviewed
- Profile ownership
- Not yet claimed
- Last reviewed
- May 16, 2026

